Article
Novel trimethoprim resistance gene dfrA34 identified in Salmonella Heidelberg in the USA
22 Aug 2018
Abstract excerpt
Background: Trimethoprim/sulfamethoxazole is a synthetic antibiotic combination recommended for the treatment of complicated non-typhoidal Salmonella infections in humans. Resistance to trimethoprim/sulfamethoxazole is mediated by the acquisition of mobile genes, requiring both a dfr gene (trimethoprim resistance) and a sul gene (sulfamethoxazole resistance) for a clinical resistance phenotype (MIC ≥4/76 mg/L)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
